Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | CA12 | O43570 | 2/20 | 0.64 |
| ▸ | CA1 | P00915 | 2/20 | 0.64 |
| ▸ | CA2 | P00918 | 2/20 | 0.64 |
| ▸ | CA9 | Q16790 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | BRD4 | O60885 | 1/20 | 0.64 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.64 |
| ▸ | MB | P02144 | 1/20 | 0.64 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.64 |
| ▸ | CA3 | P07451 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | RARG | P13631 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6036738 | 0.88 | SMN1; SMN2 (0.53) | SMN1; SMN2L3MBTL1HTTKMT2AMEN1 | |
| SCHEMBL19227686 | 0.88 | MAPT (0.71) | SMN1; SMN2L3MBTL1HTTKMT2AMEN1 | |
| SCHEMBL861674 | 0.87 | SMN1; SMN2 (0.84) | SMN1; SMN2L3MBTL1HTTKMT2AMEN1 | |
| SCHEMBL14336092 | 0.85 | SMN1; SMN2 (0.56) | SMN1; SMN2L3MBTL1HTTKMT2AMEN1 | |
| SCHEMBL19707415 | 0.80 | CA12 (0.68) | SMN1; SMN2KMT2AMEN1MAPTCA12 | |
| SCHEMBL3818831 | 0.80 | SMN1; SMN2 (1.00) | SMN1; SMN2L3MBTL1HTTKMT2AMEN1 | |
| SCHEMBL11158565 | 0.80 | MAPT (0.83) | SMN1; SMN2L3MBTL1HTTKMT2AMEN1 | |
| SCHEMBL8164496 | 0.79 | RXFP1 (0.62) | SMN1; SMN2L3MBTL1HTTKMT2AMEN1 | |
| SCHEMBL7094502 | 0.79 | MAPT (0.62) | HTTKMT2AMEN1ALDH1A1MAPT | |
| SCHEMBL1488126 | 0.78 | SMN1; SMN2 (0.70) | SMN1; SMN2L3MBTL1HTTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113336786-B | Diastereoselective polysubstituted naphthenic compound and preparation method thereof | 南京工业大学 | 2022-10-18 | — | — | CN | claimed |
| CN-111484503-B | Mikanolide derivative and preparation method and application thereof | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2022-05-27 | — | — | CN | claimed |
| CN-113336786-A | Diastereoselective polysubstituted naphthenic compound and preparation method thereof | 南京工业大学 | 2021-09-03 | — | — | CN | claimed |
| CN-108017557-B | Cyanidation method for preparing nitrile compound | 中国科学院兰州化学物理研究所苏州研究院 | 2020-11-24 | — | — | CN | claimed |
| CN-111499566-A | Pyridine derivative compound and preparation method thereof | 南京工业大学 | 2020-08-07 | — | — | CN | claimed |
| CN-111484503-A | Mikanolide derivative and preparation method and application thereof | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2020-08-04 | — | — | CN | claimed |
| US-7122694-B2 | Hydroboronation process | BORON MOLECULAR PTY LIMITED (AU) | 2006-10-17 | — | — | US | claimed |
| US-20040133028-A1 | Hydroboronation process | COMMONWEALTH SCIENTIFIC | 2004-07-08 | — | — | US | claimed |
| EP-1127060-B1 | HYDROBORONATION PROCESS | COMMW SCIENT IND RES ORG (AU) | 2004-04-07 | — | — | EP | claimed |
| US-20020015826-A1 | Zwitterionic iodonium compounds and methods of application | CLEMSON UNIVERSITY | 2002-02-07 | — | — | US | claimed |
| JP-60056928-A | — | — | None | — | — | JP | disclosed |
| US-12325696-B2 | Indazole derivative, preparation method therefor, and pharmaceutical application thereof | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2025-06-10 | — | — | US | disclosed |
| CN-120004934-A | Preparation method of benzo-silicon-containing octatomic ring compound | 郑州大学 | 2025-05-16 | — | — | CN | disclosed |
| CN-119320379-A | Indazole derivative, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2025-01-17 | — | — | CN | disclosed |
| US-20240325573-A1 | X-RAY DEVELOPABLE MOLECULE, EMBOLISM MICROSPHERE AND PREPARATION METHODS THEREFOR | SHANGHAI HUIHE HEALTHCARE TECHNOLOGY CO., LTD. (CN) | 2024-10-03 | — | — | US | disclosed |
| US-4990505-A | Treating asthma, bronchitis; adrenergic stimulants | GLAXO GROUP LIMITED (GB) | 1991-02-05 | — | — | US | disclosed |
| EP-0391212-A2 | Process for preparing bifunctional Z-stilbene compounds, new bifunctional Z-stilbene compounds and their use for preparing polymers | BAYER AG (DE) | 1990-10-10 | — | — | EP | disclosed |
| US-4567280-A | NITROGEN DIOXIDE; BY-PRODUCT INHIBITION | UBE INDUSTRIES, LTD. (JP) | 1986-01-28 | — | — | US | disclosed |
| JP-S6056928-A | PRODUCTION OF AROMATIC IODINE COMPOUND | UBE IND LTD | 1985-04-02 | — | — | JP | disclosed |
| US-4186153-A | Process for 1,2,4,5-tetrachlorobenzene | THE DOW CHEMICAL COMPANY (US) | 1980-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020015826-A1 | Zwitterionic iodonium compounds and methods of application | DGKI, DSTN, PCNA | SMN1; SMN2 3658/4885L3MBTL1 3773/4885HTT 2915/4885 |
| US-20240325573-A1 | X-RAY DEVELOPABLE MOLECULE, EMBOLISM MICROSPHERE AND PREPARATION METHODS THEREFOR | F11, FAR1, FGB | SMN1; SMN2 4879/4885L3MBTL1 1061/4885HTT 3530/4885 |
| US-20040133028-A1 | Hydroboronation process | ALKBH3, HPD, HVCN1 | SMN1; SMN2 4416/4885L3MBTL1 1650/4885HTT 588/4885 |
| US-12325696-B2 | Indazole derivative, preparation method therefor, and pharmaceutical application thereof | CYP19A1, HSD17B11, CYP51A1 | SMN1; SMN2 4872/4885L3MBTL1 4740/4885HTT 4712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.